Be in the know. 15 key reads for Saturday…

  1. FDA Advisory Committee Votes in Favor of Biogen Alzheimer’s Drug (barrons)
  2. Opinion: Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays. (marketwatch)
  3. AI Stocks Aren’t in a Bubble. Look at the Numbers. (barrons)
  4. Why ‘Shareholder Yield’ Is Better Than Dividend Yield. Where to Find It. (barrons)
  5. Accelerated adoption of AI will drive growth in the public cloud players (barrons)
  6. Molson Coors Gets Another Bud Light-Driven Upgrade (barrons)
  7. Snowflake Stock Sees Big Buy From Director Mark D. McLaughlin (barrons)
  8. Copper Traders Are Net Long. That’s a Good Sign for the Red Metal. (barrons)
  9. Here’s the main driver of the S&P 500’s bull-market rally, according to Fundstrat’s Tom Lee (marketwatch)
  10. Vista Equity President David Breach Sees Early Signs of Relief in IPO Bottleneck (bloomberg)
  11. US Household Net Worth Climbs as Stock Rally Offsets Real Estate Drop (bloomberg)
  12. The stock market is headed for a critical week as investors brace for new inflation data and a key Fed meeting (businessinsider)
  13. 10 Best Blue-Chip Stocks to Buy for the Long Term (morningstar)
  14. 5 Book Recommendations From Mohnish Pabrai (acquirersmultiple)
  15. JPMorgan CEO Jamie Dimon: The economy is still doing fine (cnbc)